ELAN Stock News & Catalysts – Elanco Animal Health

FEATURED

Elanco Animal Health Reports Third Quarter 2026 Results

Accelerated Price, Organic Constant Currency Revenue Growth, and Gross Margin Expansion; Raising Full Year Outlook and Innovation Target; Achieved 2.9x Net Leverage Ratio MilestoneThird Quarter 2026 Financial

Summary

Nov 6, 2026, 6:27 AM ·PRNewswire

RECENT

October Consumer Research Confirms Pet Health Remains Non-Negotiable Household Priority

Latest U.S. Survey of 2,000+ Consumers Shows 93% of Pet Owners Maintained or Increased Pet Spending in Past Three Months, Omnichannel Shift Redefines PurchasingINDIANAPOLIS, Nov. 6, 2026 /PRNewswire/ -- Elanco Animal

Nov 6, 2026, 6:27 AM ·PRNewswire

Elanco to Participate in UBS Global Healthcare Conference

INDIANAPOLIS, Nov. 3, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) will attend the UBS Global Healthcare Conference on November 9, 2026. Bob VanHimbergen, executive vice president and CFO, and

Nov 3, 2026, 7:53 AM ·PRNewswire

Elanco Animal Health Appoints Jamie Preston as Chief People Officer

Preston brings more than two decades of global HR leadership and workforce innovation experience; Dave Kinard to retire at year-endINDIANAPOLIS, Oct. 22, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:

Oct 22, 2026, 6:53 AM ·PRNewswire

Elanco to Participate in BofA Securities Global Healthcare Conference 2026

INDIANAPOLIS, Sept. 17, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) will attend the BofA Securities Global Healthcare Conference 2026 on September 22, 2026. Jeff Simmons, president and CEO, will

Sep 17, 2026, 7:57 AM ·PRNewswire

Expanding Tick and Itch Season Supports Momentum in Elanco Innovation, Meeting Pet Owner Demand for Health and Wellness Care

Innovation that protects against these pests is driving stronger Elanco base business and overall share gains.Elanco confirms U.S. Pet Health is on track to expectations of high-single digit to low double-digit growth

Sep 15, 2026, 6:27 AM ·PRNewswire

Elanco Confirms Date and Conference Call for Third Quarter 2026 Financial Results Announcement

INDIANAPOLIS, Sept. 11, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) will announce its third quarter 2026 financial results on Friday, November 6, 2026. Elanco will also conduct a conference call

Sep 11, 2026, 7:58 AM ·PRNewswire

Elanco to Participate in Morgan Stanley 24th Annual Global Healthcare Conference

INDIANAPOLIS, Sept. 10, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) will attend the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026. Jeff Simmons, president and CEO,

Sep 10, 2026, 7:58 AM ·PRNewswire

Elanco Scales Biologics Capabilities with Expansion of Kansas Manufacturing Facility

The completed 25,000-square-foot Elwood site expansion bolsters Elanco's monoclonal antibody (mAb) production; supports delivery of next-generation pipelineINDIANAPOLIS, Aug. 26, 2026 /PRNewswire/ -- Elanco Animal

Aug 26, 2026, 8:30 AM ·PRNewswire

Elanco's CLiK™ Extra (dicyclanil topical suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Species

Vigilance and early intervention are key to minimizing animal injury and limiting the parasite's spread, according to Elanco's technical expertsEmergency Use Authorization for Elanco's CLiK Extra provides

Aug 7, 2026, 2:20 PM ·PRNewswire

Elanco Animal Health Reports Second Quarter 2026 Results

Raising Full Year Outlook and Innovation Target, Improving Year-End Net Leverage Ratio TargetSecond Quarter 2026 Financial Results: Revenue of $1,368 million, an increase of 10% year-over-year; 8% organic constant

Aug 5, 2026, 6:27 AM ·PRNewswire

Elanco Releases 2025 Impact Report, Demonstrating How Animal Health Helps Meet Society's Growing Needs

Report highlights Elanco's impact through innovation, expanded access to animal care, a stronger and more sustainable food system and investment in people and communitiesINDIANAPOLIS, July 31, 2026 /PRNewswire/ --

Jul 31, 2026, 7:32 AM ·PRNewswire

Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Kills Ticks¹ Faster² than Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) and NexGard® Plus (afoxolaner, moxidectin, and pyrantel chewable tablets)

Published Data Shows that the Active Ingredient, Lotilaner, in Credelio Quattro:Kills existing black-legged tick (Ixodes scapularis) infestations faster2 than leading competitors, within just 8 hours of treatment.iKills

Jul 22, 2026, 6:27 AM ·PRNewswire

Elanco Confirms Date and Conference Call for Second Quarter 2026 Financial Results Announcement

INDIANAPOLIS, July 8, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) will announce its second quarter 2026 financial results on Wednesday, August 5, 2026. Elanco will also conduct a conference call

Jul 8, 2026, 8:00 AM ·PRNewswire

Elanco to Launch Elanco Ventures with $25 Million Multi-Year Commitment to Accelerate Innovation in Animal Health

New corporate venture capital platform will invest to advance therapeutics, technologies and One Health solutionsINDIANAPOLIS, June 18, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) today announced

Jun 18, 2026, 7:26 AM ·PRNewswire

Elanco Animal Health Incorporated ELAN · News